--------------:--
¥¹¥Ý¥ó¥µ¡¼¥µ¥¤¥È
2011-06-12-Sun-00:00
FOLFIRINOX vs GEM
¤ªµ×¤·¤Ö¤ê¤Ç¤¹¡£À¸¤¤Æ¤Þ¤¹¡£
ºÇ¶áÆÉ¤ó¤ÀÏÀʸ¤è¤ê¡£¿Ê¹Ôç¹´â¤ËÂФ¹¤ë²½³ØÎÅË¡¤Î¥ì¥¸¥á¥ó¤ÎÏá£
FOLFIRINOX¤¬¸½ºß¤Î1st line¤Ç¤¢¤ëGEMñºÞ¤è¤êÎɤ¤¤Î¤Ç¤Ï¤Ê¤¤¤«¤È¤¤¤¦Ïá£
phase·¤ÎRCT¤Ç¤¹¡£
¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatin Cancer
Thierry Conoroy et al., NEJM 364;19
ÇØ·Ê
ž°ÜÀç¹Â¡´â¤ËÂФ·¤ÆFOLFIRINOX¤È1stline¤Ç¤¢¤ëGEM¤È¤ò¸ú²Ì¡¦°ÂÁ´Ì̤ÇÈæ³Ó¤·¤¿¥Ç¡¼¥¿¤ÏÉÔ¤·¤Æ¤¤¤ë¡£
ÊýË¡
PS0-1¤Î´µ¼Ô342¿Í¤òFOLFIRINOX¤ÈGEM¤Ë¥é¥ó¥À¥Þ¥¤¥º¤·¤¿¡£¸ú²Ì¤¬¤¢¤ë´µ¼Ô¤Ë¤Ï6¥«·î¤Î²½³ØÎÅË¡·Ñ³¤ò¿ä¾©¤·¤¿¡£
primary endpoint¤ÏOS¤ËÃÖ¤¤¤¿¡£secondary endpoint¤ÏPFS¡¢¼ðáç¤ÎÈ¿±þÀ¡¢°ÂÁ´ÀQOL¡£
·ë²Ì
OSÃæ±ûÃͤÏFOLFIRINOX¤Ç11.1¥«·î¡¢GEM¤Ç6.8¥«·î¡£»àË´¤ÎHR¤Ï0.57(0.45-0.73 p<0.001)¤Ç¥Ý¥¸¥Æ¥£¥Ö¡£
PFSÃæ±ûÃͤÏFOLFIRINOX¤Ç6.4m¡¢GEM¤Ç3.3m¡£HR0.47(0.37-0.59 p<0.001)
objective response FOLFIRINOX 31.6%¡¢GEM9.4%¡¡p<0.001
ͳ²»ö¾Ý¤ÏFOLFIRINOX¤Ç¤è¤ê¿¤¯¤ß¤é¤ì¤¿¡£È¯Ç®À¹¥Ãæµå¸º¾¯¾É¤Ï5.4%¤Ë¸«¤é¤ì¤¿¡£6¥«·î¤Î»þÅÀ¤Ç¤ÎÌÀ³Î¤ÊQOL¤ÎÄã²¼¤ÏFOLFIRINOX·²¤Ç31%¡¢GEM¤Ç66%¤Ë¤ß¤é¤ì¡¢HR¤Ï0.47(0.30-0.70 p<0.001)¤Ç¤¢¤Ã¤¿¡£
·ëÏÀ
FOLFIRINOX¤ÏGEM¤ËÈæ¤Ù¤ÆÀ¸Â¸¤¬¿¤Ó¡¢°ìÊý¤ÇÆÇÀ¤ÏÁý²Ã¤¹¤ë¡£FOLFIRINOX¤ÏPS¤¬Îɹ¥¤Êž°ÜÀç¹Â¡´â¤Î1¤Ä¤Î¥ª¥×¥·¥ç¥ó¤Ë¤Ê¤ê¤¦¤ë¡£
¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²
ç¹´â¤Ï¸«¤Ä¤«¤Ã¤¿¤È¤¤Ë¤Ï¥¤¥ó¥ª¥Ú¡Ê¼ê½ÑÉÔǽ¡Ë¤Ê¤³¤È¤â¿¤¯¡¢²½³ØÎÅË¡¤â¤Ñ¤Ã¤È¤·¤Ê¤¤¤Î¤Ç¤¹¤¬¡£
º£¤Þ¤Ç¤ÏÍ£°ìGEMñºÞ¤¬Í½¸å¤ò²þÁ±¤¹¤ë¤È¤µ¤ì¤Æ¤¤¤Þ¤·¤¿¡£
¤Ç¡¢º£²ó¤ÎFOLFIRINOX¡£
ÂçIJ´â¤Î¥ì¥¸¥á¥ó¤ËFOLFOX¤ÈFOLFIRI¤È¸À¤¦¥ì¥¸¥á¥ó¤¬¤¢¤ë¤Î¤Ç¤¹¤¬¡¢¤³¤¤¤Ä¤é¤ò¤¯¤Ã¤Ä¤±¤Æ²¿¤Ç¤âÆþ¤ì¤Æ¤ä¤í¤¦¤È¤¤¤¦¤Î¤¬¡¢¤³¤ÎFOLFIRINOX¡£
·ë²Ì¤È¤·¤Æ¤ÏOS¤¬¤Ó¤Ã¤¯¤ê¤¹¤ë¤°¤é¤¤¿¤Ó¤Æ¤¤¤Þ¤¹¡£
FOLFIRINOX¤Î¥ì¥¸¥á¥ó¤Ë»È¤ï¤ì¤ëÌôºÞ¤Ç̤¾µÇ§¤Î¤â¤Î¤Ï̵¤¤¤Î¤Ç¡¢Êݸ±¤Çç¹´â¤Ø¤ÎŬ±þ¤¬Ç§¤á¤é¤ì¤ì¤Ð1st line¤Ë¤Ê¤ê¤¦¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£
¤¿¤À¤·¡¢¸µµ¤¤Ê¿Í¸ÂÄê¤Ç¤¹¤±¤É¤Í¡£discussion¤Ç¤â½ñ¤¤¤Æ¤¢¤Ã¤¿¤¬¡¢T-Bil¤ò1.5¤ÇÀڤäƤ¤¤ë¤Î¤Çç¹Æ¬Éô¤¬¤ó¤Ï¾¯¤Ê¤«¤Ã¤¿¤³¤È¤â¹Íθ¤ËÆþ¤ì¤ë¤Ù¤¤«¤È¡£
¤Û¤¤¤Ç¡¢¤³¤Î»î¸³¤ÎÆÃµ¤¹¤Ù¤»ö¹à¤ÏQOL¤ò²òÀÏÂоݤ˲䨤Ƥ¤¤ë¤³¤È¡£
ͽ¸å¿¤Ó¤Æ¤â¡¢É±¡¤Î¥Ù¥Ã¥È¤Ç¿²¤Æ¤ë¤À¤±¤Î»þ´Ö¤¬±ä¤Ó¤Æ¤â»ÅÊý¤Ê¤¤¤â¤Î¤Í¡£
º£²ó¤Î·ë²Ì¤Ç¤Ï¡¢6¥«·î¸å¤ÎQOL¤ÎÄã²¼¤¬FOLFIRINOX·²¤ÇͰդËÄ㤫¤Ã¤¿¡£¤Ä¤Þ¤ê¿Ê¹Ô¤ÎÍÞÀ©¤¬QOL²þÁ±¤Ë·ë¤Ó¤Ä¤¯¤³¤È¤¬¼¨¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¿Ê¹Ôç¹´â¤Î¿·µ¬¥ì¥¸¥á¥ó¤Ç¤ÏGEMñºÞvsGEM+elrotinib(¥¿¥ë¥»¥Ð®)¤ÇGEM+elrotinib¤¬OS¤ò0.33¥«·î±ä¤Ð¤·¤Æ²¿¤È¤«¥Ý¥¸¥Æ¥£¥Ö¤Ê·ë²Ì½Ð¤·¤Æ¤¿¤±¤É¡¢Ê¬»ÒɸŪÌô¤Ç¤¢¤ë¥¿¥ë¥»¥Ð¤ÏÈó¾ï¤Ë¹â²Á¤Ê¤Î¤ÇÈñÍÑÂиú²Ì¤Ë¤Ïµ¿Ìä¡£
º£Ç¯¤ÎASCO¤Ç¤ÏGEM vs S-1 vs GEM+S-1¤Ç¡¢S-1¤ÎGEM¤ËÂФ¹¤ëÈóÎôÀ¤¬¼¨¤µ¤ì¤Æ¤Þ¤·¤¿¡£S-1¤â1st line¤Î¥ª¥×¥·¥ç¥ó¤Ë¤Ê¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£
°ìÊý¡¢GEM+S-1¤ÏPFS¤ò±äŤ·¤¿¤â¤Î¤Î¡¢OS¤Ë¤ÏͰդʱäĹ¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¤è¤¦¤Ç¤¹¡£¤¿¤À¤·QOL¤ÏÎɤ«¤Ã¤¿¡£
¼¡¡¹¿·¤·¤¤Ï䬽ФƤ¤ÆÌÌÇò¤¤¤Î¤Ç¤¹¤¬¡¢¤È¤ê¤¢¤¨¤º¤Ï¹ñ»î¤Ë¤¦¤«¤Ã¤Æ°å¼Ô¤Ë¤Ê¤é¤ó¤È¤Í^^;
³¤¤Ïά¸ì½¸¤Ç¤¹
ºÇ¶áÆÉ¤ó¤ÀÏÀʸ¤è¤ê¡£¿Ê¹Ôç¹´â¤ËÂФ¹¤ë²½³ØÎÅË¡¤Î¥ì¥¸¥á¥ó¤ÎÏá£
FOLFIRINOX¤¬¸½ºß¤Î1st line¤Ç¤¢¤ëGEMñºÞ¤è¤êÎɤ¤¤Î¤Ç¤Ï¤Ê¤¤¤«¤È¤¤¤¦Ïá£
phase·¤ÎRCT¤Ç¤¹¡£
¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatin Cancer
Thierry Conoroy et al., NEJM 364;19
ÇØ·Ê
ž°ÜÀç¹Â¡´â¤ËÂФ·¤ÆFOLFIRINOX¤È1stline¤Ç¤¢¤ëGEM¤È¤ò¸ú²Ì¡¦°ÂÁ´Ì̤ÇÈæ³Ó¤·¤¿¥Ç¡¼¥¿¤ÏÉÔ¤·¤Æ¤¤¤ë¡£
ÊýË¡
PS0-1¤Î´µ¼Ô342¿Í¤òFOLFIRINOX¤ÈGEM¤Ë¥é¥ó¥À¥Þ¥¤¥º¤·¤¿¡£¸ú²Ì¤¬¤¢¤ë´µ¼Ô¤Ë¤Ï6¥«·î¤Î²½³ØÎÅË¡·Ñ³¤ò¿ä¾©¤·¤¿¡£
primary endpoint¤ÏOS¤ËÃÖ¤¤¤¿¡£secondary endpoint¤ÏPFS¡¢¼ðáç¤ÎÈ¿±þÀ¡¢°ÂÁ´ÀQOL¡£
·ë²Ì
OSÃæ±ûÃͤÏFOLFIRINOX¤Ç11.1¥«·î¡¢GEM¤Ç6.8¥«·î¡£»àË´¤ÎHR¤Ï0.57(0.45-0.73 p<0.001)¤Ç¥Ý¥¸¥Æ¥£¥Ö¡£
PFSÃæ±ûÃͤÏFOLFIRINOX¤Ç6.4m¡¢GEM¤Ç3.3m¡£HR0.47(0.37-0.59 p<0.001)
objective response FOLFIRINOX 31.6%¡¢GEM9.4%¡¡p<0.001
ͳ²»ö¾Ý¤ÏFOLFIRINOX¤Ç¤è¤ê¿¤¯¤ß¤é¤ì¤¿¡£È¯Ç®À¹¥Ãæµå¸º¾¯¾É¤Ï5.4%¤Ë¸«¤é¤ì¤¿¡£6¥«·î¤Î»þÅÀ¤Ç¤ÎÌÀ³Î¤ÊQOL¤ÎÄã²¼¤ÏFOLFIRINOX·²¤Ç31%¡¢GEM¤Ç66%¤Ë¤ß¤é¤ì¡¢HR¤Ï0.47(0.30-0.70 p<0.001)¤Ç¤¢¤Ã¤¿¡£
·ëÏÀ
FOLFIRINOX¤ÏGEM¤ËÈæ¤Ù¤ÆÀ¸Â¸¤¬¿¤Ó¡¢°ìÊý¤ÇÆÇÀ¤ÏÁý²Ã¤¹¤ë¡£FOLFIRINOX¤ÏPS¤¬Îɹ¥¤Êž°ÜÀç¹Â¡´â¤Î1¤Ä¤Î¥ª¥×¥·¥ç¥ó¤Ë¤Ê¤ê¤¦¤ë¡£
¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²¡²
ç¹´â¤Ï¸«¤Ä¤«¤Ã¤¿¤È¤¤Ë¤Ï¥¤¥ó¥ª¥Ú¡Ê¼ê½ÑÉÔǽ¡Ë¤Ê¤³¤È¤â¿¤¯¡¢²½³ØÎÅË¡¤â¤Ñ¤Ã¤È¤·¤Ê¤¤¤Î¤Ç¤¹¤¬¡£
º£¤Þ¤Ç¤ÏÍ£°ìGEMñºÞ¤¬Í½¸å¤ò²þÁ±¤¹¤ë¤È¤µ¤ì¤Æ¤¤¤Þ¤·¤¿¡£
¤Ç¡¢º£²ó¤ÎFOLFIRINOX¡£
ÂçIJ´â¤Î¥ì¥¸¥á¥ó¤ËFOLFOX¤ÈFOLFIRI¤È¸À¤¦¥ì¥¸¥á¥ó¤¬¤¢¤ë¤Î¤Ç¤¹¤¬¡¢¤³¤¤¤Ä¤é¤ò¤¯¤Ã¤Ä¤±¤Æ²¿¤Ç¤âÆþ¤ì¤Æ¤ä¤í¤¦¤È¤¤¤¦¤Î¤¬¡¢¤³¤ÎFOLFIRINOX¡£
·ë²Ì¤È¤·¤Æ¤ÏOS¤¬¤Ó¤Ã¤¯¤ê¤¹¤ë¤°¤é¤¤¿¤Ó¤Æ¤¤¤Þ¤¹¡£
FOLFIRINOX¤Î¥ì¥¸¥á¥ó¤Ë»È¤ï¤ì¤ëÌôºÞ¤Ç̤¾µÇ§¤Î¤â¤Î¤Ï̵¤¤¤Î¤Ç¡¢Êݸ±¤Çç¹´â¤Ø¤ÎŬ±þ¤¬Ç§¤á¤é¤ì¤ì¤Ð1st line¤Ë¤Ê¤ê¤¦¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¡£
¤¿¤À¤·¡¢¸µµ¤¤Ê¿Í¸ÂÄê¤Ç¤¹¤±¤É¤Í¡£discussion¤Ç¤â½ñ¤¤¤Æ¤¢¤Ã¤¿¤¬¡¢T-Bil¤ò1.5¤ÇÀڤäƤ¤¤ë¤Î¤Çç¹Æ¬Éô¤¬¤ó¤Ï¾¯¤Ê¤«¤Ã¤¿¤³¤È¤â¹Íθ¤ËÆþ¤ì¤ë¤Ù¤¤«¤È¡£
¤Û¤¤¤Ç¡¢¤³¤Î»î¸³¤ÎÆÃµ¤¹¤Ù¤»ö¹à¤ÏQOL¤ò²òÀÏÂоݤ˲䨤Ƥ¤¤ë¤³¤È¡£
ͽ¸å¿¤Ó¤Æ¤â¡¢É±¡¤Î¥Ù¥Ã¥È¤Ç¿²¤Æ¤ë¤À¤±¤Î»þ´Ö¤¬±ä¤Ó¤Æ¤â»ÅÊý¤Ê¤¤¤â¤Î¤Í¡£
º£²ó¤Î·ë²Ì¤Ç¤Ï¡¢6¥«·î¸å¤ÎQOL¤ÎÄã²¼¤¬FOLFIRINOX·²¤ÇͰդËÄ㤫¤Ã¤¿¡£¤Ä¤Þ¤ê¿Ê¹Ô¤ÎÍÞÀ©¤¬QOL²þÁ±¤Ë·ë¤Ó¤Ä¤¯¤³¤È¤¬¼¨¤µ¤ì¤Æ¤¤¤Þ¤¹¡£
¿Ê¹Ôç¹´â¤Î¿·µ¬¥ì¥¸¥á¥ó¤Ç¤ÏGEMñºÞvsGEM+elrotinib(¥¿¥ë¥»¥Ð®)¤ÇGEM+elrotinib¤¬OS¤ò0.33¥«·î±ä¤Ð¤·¤Æ²¿¤È¤«¥Ý¥¸¥Æ¥£¥Ö¤Ê·ë²Ì½Ð¤·¤Æ¤¿¤±¤É¡¢Ê¬»ÒɸŪÌô¤Ç¤¢¤ë¥¿¥ë¥»¥Ð¤ÏÈó¾ï¤Ë¹â²Á¤Ê¤Î¤ÇÈñÍÑÂиú²Ì¤Ë¤Ïµ¿Ìä¡£
º£Ç¯¤ÎASCO¤Ç¤ÏGEM vs S-1 vs GEM+S-1¤Ç¡¢S-1¤ÎGEM¤ËÂФ¹¤ëÈóÎôÀ¤¬¼¨¤µ¤ì¤Æ¤Þ¤·¤¿¡£S-1¤â1st line¤Î¥ª¥×¥·¥ç¥ó¤Ë¤Ê¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£
°ìÊý¡¢GEM+S-1¤ÏPFS¤ò±äŤ·¤¿¤â¤Î¤Î¡¢OS¤Ë¤ÏͰդʱäĹ¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¤è¤¦¤Ç¤¹¡£¤¿¤À¤·QOL¤ÏÎɤ«¤Ã¤¿¡£
¼¡¡¹¿·¤·¤¤Ï䬽ФƤ¤ÆÌÌÇò¤¤¤Î¤Ç¤¹¤¬¡¢¤È¤ê¤¢¤¨¤º¤Ï¹ñ»î¤Ë¤¦¤«¤Ã¤Æ°å¼Ô¤Ë¤Ê¤é¤ó¤È¤Í^^;
³¤¤Ïά¸ì½¸¤Ç¤¹
2011-03-30-Wed-21:32
Ê¡Åç¤Ï¶Ø´÷¡£
̵ºá¤È¸À¤ï¤ì³¤±¤¿°å»Õ¤òŰÄìŪ¤ËÈȺá¿Í¤Ë»ÅΩ¤Æ¾å¤²¤è¤¦¤È¤·¤¿¤Î¤¬Ê¡ÅçÃϸ¡¡£
ÈȺáÁܺº¤ËÂŶ¨¤·¤Ê¤¤»ÑÀª¤Ê¤Î¤«¤È»×¤¤¤¤ä¡¢¿ÌºÒÆÃ¼Ï¤ò¾¡¼ê¤ËÍ¿¤¨¤è¤Ã¤¿¡£
¤¢¤ÎÀèÀ¸¤Î»þ¤â¸øÈ½°Ý»ý¤Ï̵Íý¤À¤È¸À¤ï¤ì¤Æ¤¿¤Î¤Ë¤Í¤§¡£
¤³¤ó¤Ê¸¡»¡¤Î¶»»°À£¤Ç(¼Ò²ñŪ¤Ê)ÈȺá¼Ô or not¤¬·è¤Þ¤ë¾ì½ê¤ÇƯ¤±¤Þ¤»¤ó¤è¤Í¡£
ÈȺáÁܺº¤ËÂŶ¨¤·¤Ê¤¤»ÑÀª¤Ê¤Î¤«¤È»×¤¤¤¤ä¡¢¿ÌºÒÆÃ¼Ï¤ò¾¡¼ê¤ËÍ¿¤¨¤è¤Ã¤¿¡£
¤¢¤ÎÀèÀ¸¤Î»þ¤â¸øÈ½°Ý»ý¤Ï̵Íý¤À¤È¸À¤ï¤ì¤Æ¤¿¤Î¤Ë¤Í¤§¡£
¤³¤ó¤Ê¸¡»¡¤Î¶»»°À£¤Ç(¼Ò²ñŪ¤Ê)ÈȺá¼Ô or not¤¬·è¤Þ¤ë¾ì½ê¤ÇƯ¤±¤Þ¤»¤ó¤è¤Í¡£
2011-03-15-Tue-20:59
¿ÌºÒ¤Ç¤ï¤«¤Ã¤¿¤³¤È
Èó¾ï»þ¤Ë´Ù¤ì¤Ð¡¢¤³¤ó¤À¤±¤½¤½¤¯¤µ¤È"Êì¹ñ"¤Ë¤ªµ¢¤ê¤Ë¤Ê¤ë¤é¤·¤¤¡£
¤ä¤Ï¤ê¤³¤ó¤Ê¤ä¤Ä¤é¤Ë»²À¯¸¢¤Ê¤ÉÍ¿¤¨¤Æ¤Ï¤¤¤±¤Ê¤¤¡£
¹ñ¤Î°ì°÷¤È¤·¤Æ¤ÎÀÕǤ¤òÊü´þ¤Ç¤¤ë¤ï¤±¤Ç¤¹¤«¤é¡£
¤à¤·¤í¡¢¤ª¤¤¤Æ¤ä¤Ã¤Æ¤ë¤ó¤À¤«¤é¤·¤Ã¤«¤êÀǶâʧ¤¨¤È¡£
ÄÉħ¤·¤Æ¤â¤¤¤¤¤¯¤é¤¤¤¸¤ã¤Ê¤¤¤À¤í¤¦¤«¡£¤¿¤À¤Ç¤µ¤¨Ê§¤ï¤Ê¤¤¤Î¤À¤·¡£
³¤³°¤ÎÉÞÍܿͿô¤Ê¤ó¤Æ¤ï¤«¤Ã¤¿¤â¤ó¤¸¤ã¤Ê¤¤¤Î¤À¤«¤é¡¢³¤³°¤ÎÉÞÍܼԤϹµ½üŬ±þ³°¤Ë¤·¤Æ¤·¤Þ¤¨¡£
¤·¤«¤ë¤Ù¤¿Í¤Ë¤Ï̱´Ö¤¬ÉÞÍܼêÅö¤ò;·×¤Ë½Ð¤·¤Æ¤Ç¤â°ú¤ÃÄ¥¤Ã¤ÆÍè¤ë¤Ç¤·¤ç¤¦¤·¡£
¤Þ¤¡¡¢¤ªµ¢¤ê¤Ë¤Ê¤Ã¤¿¤Þ¤Þµ¢¤Ã¤Æ¤³¤Ê¤¤ã¤½¤ì¤¬°ìÈ֤Ǥ·¤ç¤¦¤«¤Í¡Á¡©
¤ä¤Ï¤ê¤³¤ó¤Ê¤ä¤Ä¤é¤Ë»²À¯¸¢¤Ê¤ÉÍ¿¤¨¤Æ¤Ï¤¤¤±¤Ê¤¤¡£
¹ñ¤Î°ì°÷¤È¤·¤Æ¤ÎÀÕǤ¤òÊü´þ¤Ç¤¤ë¤ï¤±¤Ç¤¹¤«¤é¡£
¤à¤·¤í¡¢¤ª¤¤¤Æ¤ä¤Ã¤Æ¤ë¤ó¤À¤«¤é¤·¤Ã¤«¤êÀǶâʧ¤¨¤È¡£
ÄÉħ¤·¤Æ¤â¤¤¤¤¤¯¤é¤¤¤¸¤ã¤Ê¤¤¤À¤í¤¦¤«¡£¤¿¤À¤Ç¤µ¤¨Ê§¤ï¤Ê¤¤¤Î¤À¤·¡£
³¤³°¤ÎÉÞÍܿͿô¤Ê¤ó¤Æ¤ï¤«¤Ã¤¿¤â¤ó¤¸¤ã¤Ê¤¤¤Î¤À¤«¤é¡¢³¤³°¤ÎÉÞÍܼԤϹµ½üŬ±þ³°¤Ë¤·¤Æ¤·¤Þ¤¨¡£
¤·¤«¤ë¤Ù¤¿Í¤Ë¤Ï̱´Ö¤¬ÉÞÍܼêÅö¤ò;·×¤Ë½Ð¤·¤Æ¤Ç¤â°ú¤ÃÄ¥¤Ã¤ÆÍè¤ë¤Ç¤·¤ç¤¦¤·¡£
¤Þ¤¡¡¢¤ªµ¢¤ê¤Ë¤Ê¤Ã¤¿¤Þ¤Þµ¢¤Ã¤Æ¤³¤Ê¤¤ã¤½¤ì¤¬°ìÈ֤Ǥ·¤ç¤¦¤«¤Í¡Á¡©
2011-03-13-Sun-11:43
ÂçÃϿ̡£
¤Þ¤º¡¢ÈïºÒ¤µ¤ì¤¿Êý¡¹¤Ë¤ª¸«Éñ¤¤¿½¤·¾å¤²¤Þ¤¹¤È¤È¤â¤Ë¡¢Ë´¤¯¤Ê¤é¤ì¤¿Êý¡¹¤ª¤è¤Ó¤´°ä²¤Ë¤Ï¤ª²ù¤ä¤ß¿½¤·¾å¤²¤Þ¤¹¡£
¤µ¤Æ¡¢¥Æ¥ì¥Ó¤â¤É¤³¤ò²ó¤·¤Æ¤âÃϿ̮Êó¤Ç¤¹¤Í¡£
¤Ç¤â¤Í¡¢¤³¤ì°ÕÌ£¤¢¤ó¤Î¤«¤È»×¤¦¤ï¤±¤Ç¤¹¤è¡£
¤É¤³²ó¤·¤Æ¤âƱ¤¸¤³¤È¤ä¤Ã¤Æ¤¤¤ë¤ï¤±¤À¡£
¤Ê¤é¡¢¤¤¤Ã¤½¤Î¤³¤È¤É¤Ã¤«¥¡¼¶É£±¶É»Ä¤·¤ÆÁ´ÉôÄäÇȤ·¤Á¤Þ¤¨¤Ð¤¤¤¤¤È»×¤¦¤Î¤Ç¤¹¡£
¤½¤¦¤¹¤ì¤Ð¤É¤³¤âƱ¤¸¤è¤¦¤Ê¼èºà¤ò¤¹¤ë¤¿¤á¤Ë»È¤ï¤ì¤ëµ¡ºà¤¬ºÇ¾®¸Â¤Ë½ÐÍè¤ë¤ï¤±¤Ç¤¹¡£
ÀáÅŤˤâ¤Ò¤ç¤Ã¤È¤·¤¿¤é¤Ê¤ë¤«¤â¤Í¡£
¤É¤³¤â¤«¤·¤³¤â¥Ø¥êÈô¤Ð¤·¤Æ
"¸«¤Æ¤¯¤À¤µ¤¤¡ªSOS¤Ç¤¹!¤¢¡¢¿Í¤¬½Ð¤Æ¤¤Þ¤·¤¿!´ú¤ò¿¶¤Ã¤Æ¤Þ¤¹!!"
...¤½¤ó¤Ê¤³¤È¸À¤Ã¤Æ¤ë²Ë¤¢¤Ã¤¿¤é¹ß¤ê¤Æ¹Ô¤Ã¤Æ¸æÍÑʹ¤¤·¤í¤è¤È»×¤¦¤Î¤Ç¤¹¡£
youtube¤Ë»Ä¤Ã¤Æ¤¿
¤³¤ì¤Ç¤¹¤°¹ß¤ê¤Æ¤¤¤¯¤Ê¤ê¡¢¹ß¤ê¤ì¤Ê¤¤¤Ê¤é¤É¤¦¤Ë¤«¤·¤Æ¸½¾ì¤ÎÀ¼¤ò½¦¤Ã¤Æ¡¢¤¹¤°¤Ë»Ù±ç¤Ë¤Þ¤ï¤Ã¤¿¤È¤¤¤¦¤Ê¤éÁÇÀ²¤é¤·¤¤¤È»×¤¦¤Î¤Ç¤¹¤¬¡£
¤³¤Î¼èºà¤Ë»È¤ï¤ì¤Æ¤¤¤ë¥Ø¥ê¤Ç¾¯¤·¤Ç¤âʪ»ñ¤Ê¤ê±¿¤Ù¤Ê¤¤¤Î¤«¤Ê¤¡¡Á¤È»×¤¦¤Î¤Ç¤¹¤è¡£
ȯÅŵ¡¤È¤«¡¢±þ±ç¤ÎDr¤È¤«¡£
¤½¤ì¤³¤½¡¢ÄäÇȤ·¤¿¶É¤ÎÀ½ºîÈñ¤Ç¥Ø¥êÈô¤Ð¤·¤Æ¤ä¤ì¤Ð¤¤¤¤¡£
ÃϿ̤θå¤Ç¡¢¤ï¤¬¼Ò¤Ï¥Ø¥ê¤òÍѤ¤¤Æ¤³¤ì¤À¤±¤Î»Ù±ç¤ò¤·¤Þ¤·¤¿¡ª
¤ÎÊý¤¬¤è¤Ã¤Ý¤É´ë¶È¥¤¥á¡¼¥¸¤âÎɤ¤¤È»×¤¦¤Î¤À¤¬¡£
¤½¤ì¤Ë¡¢¼èºà¤Ç¸½ÃÏ¤ËÆþ¤Ã¤Æ¤¤¤ë¿Í´Ö¡£
¤¿¤À¤Ç¤µ¤¨¤ï¤Á¤ã¤ï¤Á¤ã¡¢¸òÄ̤Υ꥽¡¼¥¹¤â¾¯¤Ê¤¤Ãæ¤Ç¡¢Æþ¤Ã¤Æ¤âÁû¤°¤À¤±¡¢¸½¾ì¤Ë¤·¤¿¤éÌÂÏǤʤÀ¤±¤Îµ¼Ô¤¬¸òḀ̈꥽¡¼¥¹¤ò¶ô¤¦¤Î¤ÏÇ¡²¿¤Ê¤â¤Î¤«¤È»×¤¦¤Î¤Ç¤¹¤è¡£
¤³¤ó¤ÊÏäòÈþÃ̤Ȥ·¤Æ¼è¤ê¾å¤²¤é¤ì¤Æ¤¤¤ë¤¬
µÞÉ¿ͤ䵢¤ì¤Ê¤¯¤Ê¤Ã¤¿¿Í¤Ç¤´¤Ã¤¿ÊÖ¤¹É±¡¤òÆÃ¤Ë¤½¤³¤Ë¤¤¤ëɬÍפΤʤ¤µ¼ÔÏ¢Ãæ¤¬³ä¹Ô¤Ã¤Æ¤¿¤ï¤±¤Ç¤·¤ç¡©
Ƭ¤ª¤«¤·¤¤¤ó¤¸¤ã¤Ê¤¤¤«¤È»×¤¦¤Î¤Ç¤¹¤è¡£
°Ê¾å¤«¤é¡¢¼èºà¤ÏºÇÄã¸Â¤Ë¤·¤Æ¡¢¤³¤ó¤Ê»þ¤³¤½ÀáÅÙ¤¢¤ëÊ󯻤ò¤·¤¿¤é¤¤¤«¤¬¤Ç¤·¤ç¤¦¡©¤È»×¤¦¤Î¤Ç¤¹¡£
¡£¡£¡£¡£¡£
¤½¤·¤Æ¡¢¤³¤æ¤È¤¤Ëɬ¤º¤È¸À¤Ã¤Æ¤¤¤¤¤Û¤ÉȯÀ¸¤¹¤ë¥Á¥§¡¼¥ó¥á¡¼¥ë¡£
¥¦¥Á¤Ë¤Ï¥³¥¹¥âÀÐÌý¤Î¤¬Íè¤Þ¤·¤¿¤è¡£
¤³¤ó¤Ê¤Î¤ò´Êñ¤Ë²ó¤·¤Æ¤·¤Þ¤¦¥¹¥¤¡¼¥Ä(¾Ð)Ǿ¤¬¤¤¤ë¤ó¤Ç¤¹¤è¤Í¡¢¤É¤³¤ó¤Ç¤â¡£
½Ð¤É¤³¤í¤ÎÎɤ¯Ê¬¤é¤Ê¤¤¾ðÊó¤ò¤è¤¯¤â¤Þ¤¡¤³¤ó¤Ê¤ä¤¹¤ä¤¹¤È¿®¤¸¤ë¤â¤ó¤À¤ÈÊò¤ì¤Þ¤¹¡£
¥Æ¥ì¥Ó¤Ç¤â¤ä¤Ã¤Æ¤¤¤ë¤è¤¦¤Ë¡¢´ØÅì¡¢ÅìË̤ǤϷÈÂÓ¤¬·Ò¤¬¤ê¤Ë¤¯¤¯¤Ê¤Ã¤Æ¤¤¤ë¤ß¤¿¤¤¤Ç¤¹¤Í¡£
¤½¤ó¤ÊÄÌ¿®¥ê¥½¡¼¥¹¤¬ÉÔ¤·¤Æ¤¤¤ëÃæ¤Ç¡¢¥á¡¼¥ê¥¹¤Ê¤É¤Î°ìÀÆÁ÷¿®¤ò»È¤¨¤Ð¡¢¹¹¤Ë¤½¤Î¥ê¥½¡¼¥¹¤ò°µÇ÷¤¹¤ë¤ï¤±¤Ç¤¹¤è¡£
¤½¤·¤Æ¤Ê¤Ë¤è¤ê¡¢¥³¥¹¥â¤ÎHP¤ÇÌÂÏǥ᡼¥ë¤À¤È¿ïʬÁ᤯¤«¤é¹ðÃΤµ¤ì¤Æ¤¤¤¿¤ï¤±¤Ç¤¹¡£
¤Á¡¼¤È¤ÏƬ»È¤¨¤è¡¢¤È»×¤¦¤ï¤±¤Ê¤Î¤Ç¤¹¡£
¤µ¤Æ¡¢¥Æ¥ì¥Ó¤â¤É¤³¤ò²ó¤·¤Æ¤âÃϿ̮Êó¤Ç¤¹¤Í¡£
¤Ç¤â¤Í¡¢¤³¤ì°ÕÌ£¤¢¤ó¤Î¤«¤È»×¤¦¤ï¤±¤Ç¤¹¤è¡£
¤É¤³²ó¤·¤Æ¤âƱ¤¸¤³¤È¤ä¤Ã¤Æ¤¤¤ë¤ï¤±¤À¡£
¤Ê¤é¡¢¤¤¤Ã¤½¤Î¤³¤È¤É¤Ã¤«¥¡¼¶É£±¶É»Ä¤·¤ÆÁ´ÉôÄäÇȤ·¤Á¤Þ¤¨¤Ð¤¤¤¤¤È»×¤¦¤Î¤Ç¤¹¡£
¤½¤¦¤¹¤ì¤Ð¤É¤³¤âƱ¤¸¤è¤¦¤Ê¼èºà¤ò¤¹¤ë¤¿¤á¤Ë»È¤ï¤ì¤ëµ¡ºà¤¬ºÇ¾®¸Â¤Ë½ÐÍè¤ë¤ï¤±¤Ç¤¹¡£
ÀáÅŤˤâ¤Ò¤ç¤Ã¤È¤·¤¿¤é¤Ê¤ë¤«¤â¤Í¡£
¤É¤³¤â¤«¤·¤³¤â¥Ø¥êÈô¤Ð¤·¤Æ
"¸«¤Æ¤¯¤À¤µ¤¤¡ªSOS¤Ç¤¹!¤¢¡¢¿Í¤¬½Ð¤Æ¤¤Þ¤·¤¿!´ú¤ò¿¶¤Ã¤Æ¤Þ¤¹!!"
...¤½¤ó¤Ê¤³¤È¸À¤Ã¤Æ¤ë²Ë¤¢¤Ã¤¿¤é¹ß¤ê¤Æ¹Ô¤Ã¤Æ¸æÍÑʹ¤¤·¤í¤è¤È»×¤¦¤Î¤Ç¤¹¡£
youtube¤Ë»Ä¤Ã¤Æ¤¿
¤³¤ì¤Ç¤¹¤°¹ß¤ê¤Æ¤¤¤¯¤Ê¤ê¡¢¹ß¤ê¤ì¤Ê¤¤¤Ê¤é¤É¤¦¤Ë¤«¤·¤Æ¸½¾ì¤ÎÀ¼¤ò½¦¤Ã¤Æ¡¢¤¹¤°¤Ë»Ù±ç¤Ë¤Þ¤ï¤Ã¤¿¤È¤¤¤¦¤Ê¤éÁÇÀ²¤é¤·¤¤¤È»×¤¦¤Î¤Ç¤¹¤¬¡£
¤³¤Î¼èºà¤Ë»È¤ï¤ì¤Æ¤¤¤ë¥Ø¥ê¤Ç¾¯¤·¤Ç¤âʪ»ñ¤Ê¤ê±¿¤Ù¤Ê¤¤¤Î¤«¤Ê¤¡¡Á¤È»×¤¦¤Î¤Ç¤¹¤è¡£
ȯÅŵ¡¤È¤«¡¢±þ±ç¤ÎDr¤È¤«¡£
¤½¤ì¤³¤½¡¢ÄäÇȤ·¤¿¶É¤ÎÀ½ºîÈñ¤Ç¥Ø¥êÈô¤Ð¤·¤Æ¤ä¤ì¤Ð¤¤¤¤¡£
ÃϿ̤θå¤Ç¡¢¤ï¤¬¼Ò¤Ï¥Ø¥ê¤òÍѤ¤¤Æ¤³¤ì¤À¤±¤Î»Ù±ç¤ò¤·¤Þ¤·¤¿¡ª
¤ÎÊý¤¬¤è¤Ã¤Ý¤É´ë¶È¥¤¥á¡¼¥¸¤âÎɤ¤¤È»×¤¦¤Î¤À¤¬¡£
¤½¤ì¤Ë¡¢¼èºà¤Ç¸½ÃÏ¤ËÆþ¤Ã¤Æ¤¤¤ë¿Í´Ö¡£
¤¿¤À¤Ç¤µ¤¨¤ï¤Á¤ã¤ï¤Á¤ã¡¢¸òÄ̤Υ꥽¡¼¥¹¤â¾¯¤Ê¤¤Ãæ¤Ç¡¢Æþ¤Ã¤Æ¤âÁû¤°¤À¤±¡¢¸½¾ì¤Ë¤·¤¿¤éÌÂÏǤʤÀ¤±¤Îµ¼Ô¤¬¸òḀ̈꥽¡¼¥¹¤ò¶ô¤¦¤Î¤ÏÇ¡²¿¤Ê¤â¤Î¤«¤È»×¤¦¤Î¤Ç¤¹¤è¡£
¤³¤ó¤ÊÏäòÈþÃ̤Ȥ·¤Æ¼è¤ê¾å¤²¤é¤ì¤Æ¤¤¤ë¤¬
µÞÉ¿ͤ䵢¤ì¤Ê¤¯¤Ê¤Ã¤¿¿Í¤Ç¤´¤Ã¤¿ÊÖ¤¹É±¡¤òÆÃ¤Ë¤½¤³¤Ë¤¤¤ëɬÍפΤʤ¤µ¼ÔÏ¢Ãæ¤¬³ä¹Ô¤Ã¤Æ¤¿¤ï¤±¤Ç¤·¤ç¡©
Ƭ¤ª¤«¤·¤¤¤ó¤¸¤ã¤Ê¤¤¤«¤È»×¤¦¤Î¤Ç¤¹¤è¡£
°Ê¾å¤«¤é¡¢¼èºà¤ÏºÇÄã¸Â¤Ë¤·¤Æ¡¢¤³¤ó¤Ê»þ¤³¤½ÀáÅÙ¤¢¤ëÊ󯻤ò¤·¤¿¤é¤¤¤«¤¬¤Ç¤·¤ç¤¦¡©¤È»×¤¦¤Î¤Ç¤¹¡£
¡£¡£¡£¡£¡£
¤½¤·¤Æ¡¢¤³¤æ¤È¤¤Ëɬ¤º¤È¸À¤Ã¤Æ¤¤¤¤¤Û¤ÉȯÀ¸¤¹¤ë¥Á¥§¡¼¥ó¥á¡¼¥ë¡£
¥¦¥Á¤Ë¤Ï¥³¥¹¥âÀÐÌý¤Î¤¬Íè¤Þ¤·¤¿¤è¡£
¤³¤ó¤Ê¤Î¤ò´Êñ¤Ë²ó¤·¤Æ¤·¤Þ¤¦¥¹¥¤¡¼¥Ä(¾Ð)Ǿ¤¬¤¤¤ë¤ó¤Ç¤¹¤è¤Í¡¢¤É¤³¤ó¤Ç¤â¡£
½Ð¤É¤³¤í¤ÎÎɤ¯Ê¬¤é¤Ê¤¤¾ðÊó¤ò¤è¤¯¤â¤Þ¤¡¤³¤ó¤Ê¤ä¤¹¤ä¤¹¤È¿®¤¸¤ë¤â¤ó¤À¤ÈÊò¤ì¤Þ¤¹¡£
¥Æ¥ì¥Ó¤Ç¤â¤ä¤Ã¤Æ¤¤¤ë¤è¤¦¤Ë¡¢´ØÅì¡¢ÅìË̤ǤϷÈÂÓ¤¬·Ò¤¬¤ê¤Ë¤¯¤¯¤Ê¤Ã¤Æ¤¤¤ë¤ß¤¿¤¤¤Ç¤¹¤Í¡£
¤½¤ó¤ÊÄÌ¿®¥ê¥½¡¼¥¹¤¬ÉÔ¤·¤Æ¤¤¤ëÃæ¤Ç¡¢¥á¡¼¥ê¥¹¤Ê¤É¤Î°ìÀÆÁ÷¿®¤ò»È¤¨¤Ð¡¢¹¹¤Ë¤½¤Î¥ê¥½¡¼¥¹¤ò°µÇ÷¤¹¤ë¤ï¤±¤Ç¤¹¤è¡£
¤½¤·¤Æ¤Ê¤Ë¤è¤ê¡¢¥³¥¹¥â¤ÎHP¤ÇÌÂÏǥ᡼¥ë¤À¤È¿ïʬÁ᤯¤«¤é¹ðÃΤµ¤ì¤Æ¤¤¤¿¤ï¤±¤Ç¤¹¡£
¤Á¡¼¤È¤ÏƬ»È¤¨¤è¡¢¤È»×¤¦¤ï¤±¤Ê¤Î¤Ç¤¹¡£
2010-11-08-Mon-12:00
Àí³Õ¤Ë´Ø¤·¤Æ¡£
¥Ó¥Ç¥ªÎ®½Ð¤·¤Þ¤·¤¿¤Í¡£¤À¤¤¤ÖÁ°¤Ç¤¹¤¬¡£
¤Ç¡¢º£¡¢·ì´ã¤Ë¤Ê¤Ã¤ÆÈÈ¿Íõ¤·¤¬¹Ô¤ï¤ì¤Æ¤¤¤ë¤è¤¦¤ÊÊ·°Ïµ¤¤Ç¤¹¤¬¡£
¥Þ¥¹¥³¥ß¤¬¤¹¤Ã¤ÑÈ´¤¤¤¿¤é"ÆÃ¥À¥Í"¤Ç¤¢¤Ã¤Æ¡¢
°ìÈ̿ͤ¬youtube¤ËÅê¹Æ¤·¤¿¤é"ÈȺá¼Ô"¤Ê¤ó¤Ç¤¹¤Í¡£
¤ª¤«¤·¤ÊÏäǤ¹¤è¤Í¡£
¤µ¤é¤Ë¡¢¸ø³«¤»¤è¤ÈÀ¤ÏÀ¤òÀú¤Ã¤Æ¤¿¤Ï¤º¤Ê¤ó¤Ç¤¹¤è¤Í¡¢¥Þ¥¹¥³¥ß¡£
¤Ç¤â¡¢¼«Ê¬¤é¤Î¼ê¤ò·Ð¤Ê¤¤¤Ç°ìÈ̤ËήÄ̤·¤Æ¤·¤Þ¤Ã¤¿¤é°ãË¡¤Ê¤ó¤Ç¤¹¤Í¡£¤½¤¦¤Ç¤¹¤«¡£
¤¢¤ó¤¿¤éˡΧ¤Ê¤ó¤À¡©²¿ÍͤΤĤâ¤ê¡©¤Ã¤Æ¤Î¤¬´¶ÁۤǤ¹¡£
¤³¤ó¤Ê¤ó¤À¤«¤é¡¢¥Þ¥¹¡û¥ß¤Ã¤Æ¸À¤ï¤ì¤ë¤ó¤À¤ï¡£
¤Þ¤¡¤·¤«¤·¡¢À¯Éܤ¬Èó¸ø³«¡¢¤Ã¤Æ¸À¤Ã¤Æ¤¤¤ë¡¢³°¸ò¾å¤â½ÅÍפʻñÎÁ¤¬¤³¤¦¤â´Êñ¤Ëή¤ì½Ð¤ë¤Î¤Ï¤½¤ì¤Ï¤½¤ì¤ÇÌäÂê¤À¤È»×¤¤¤Þ¤¹¤¬¡£
¸ø³«¤ÈÈó¸ø³«¤Î´Ö¤ò¤È¤Ã¤Æ¡¢Î®½Ð¡¢¤È¤¤¤¦ÁªÂò»è¤ò¼è¤Ã¤¿¤Î¤«¤È¡¢Àü¤Ã¤¿¸«Êý¤â¤Ç¤¤Þ¤¹¤¬¡£
ÆÀ°Õ¤Î¶ÌÃî¿§¤Ç¡£
¤Ç¤â¤Ç¤¹¤è¡£¤½¤ì¤è¤ê½ÅÍפʤΤϡ¢À¯ÉܤÎÂбþ¤Ç¤·¤ç¤¦¡£
Ãæ¹ñÀ¯ÉܤϥӥǥªÎ®½Ð¸å¤â¡¢"ÆüËܤ¬°¤¤"¤ÎΩ¾ì¤òÊø¤µ¤º¡¢À¯Éܤ¬¸ø¼°¸«²ò¤òÏ¢Æüȯ¿®¤·¤Æ¤¤¤Þ¤¹¡£
¤·¤«¤·¡¢¤³¤Î¹ñ¤Ï¤É¤¦¤Ç¤·¤ç¤¦¡£
¸½ºß¸¡¾ÚÃæ¤Ç¤¹¢ª¤É¤¦¤ä¤é¥Ó¥Ç¥ª¤ÏËÜʪ¤é¤·¤¤¡¢Èȿͤòõ¤»
¤·¤«¥¢¥Ê¥¦¥ó¥¹¤µ¤ì¤Æ¤¤¤Ê¤¤¤è¡¼¤Êµ¤¤¬¤¹¤ë¤Î¤Ç¤¹¤¬¡£
¥Þ¥º¥´¥ß¥Õ¥£¥ë¥¿¡¼¤Ç¤·¤ç¤¦¤«¡©
ή½Ð¤·¤¿¤Î¤Ï¤Þ¤¡Îɤ¤¤È¤·¤Æ¡¢
"ή½Ð¤Ï°ä´¸¤Ç¤¹¤¬¡¢¤½¡¼¤ì¤ß¤í¡¢°¤¤¤Î¤Ï¤ª¤á¡¼¤é¤À"
¤¯¤é¤¤¤Îȯɽ¤¬¤¢¤Ã¤Æ¤â¤è¤¤¤È»×¤¤¤Þ¤¹¡£
¤È¤¤¤¦¤«¡¢¤½¤ì¤¯¤é¤¤¼çÄ¥¤·¤Ê¤¤¤ÈÀ¤³¦¤ÏÃæ¹ñ¤Î¸À¤¤Ê¬¤·¤«¤¤«¤Ê¤¤¤³¤È¤Ë¤Ê¤ë¤ó¤Ç¤¹¡£
¹ñ²ñ¤ÇÁ°¸¶Âç¿Ã¤¬
"ÎÎÅÚÌäÂê¤Ï¸ºß¤·¤Ê¤¤¤Î¤À¤«¤é·öÅÁ¤·¤Ê¤¯¤Æ¤è¤¤¡£¼Â¸ú»ÙÇÛ¤ò³¤±¤ì¤Ð¤è¤¤"
¤È¤Î¤¿¤Þ¤Ã¤Æ¤ª¤ê¤Þ¤¹¤¬¡£
Á´¤¯¸«²ò¤ò½Ò¤Ù¤Ê¤¤¤Î¤Ï¤É¤¦¤Ê¤ó¤Ç¤·¤ç¤¦¡£
¤È»×¤¦¤Î¤Ç¤¹¡£
¤·¤«¤·¡¢º£Æü¤ÎÀÐÇˤµ¤ó¡¢¥¥ì¥¥ì¤Ã¤¹¤Í¤§¡£
Àí³Õ¤Î¸å¤Î¡¢ºâÀ¯¤Î¤ªÏäÇ
"̱¼ç¼çµÁ¤ÏÆâÉôÊø²õ¤¹¤ë¡£¤¢¤ì¤â¥¿¥À¡¢¤³¤ì¤â¥¿¥À¡¢ÌµÂ̤ò¾Ê¤±¤Ð¶â¤ò¤ï¤¤¤Æ¤¯¤ë¡£¤³¤ì¤Çɼ¤ò½¸¤á¤ë¿Í¤Ï¤¤¤ë¤·¡¢¤½¤ó¤ÊͶÏǤËή¤µ¤ì¤ë¿Í¤â¤¤¤ë¡£¤·¤«¤·¤½¤ì¤Ï±³¤À¤È¤ä¤¬¤Æ¤ï¤«¤ë¡£Í¶ÏǤËή¤µ¤ì¤ë¿Í¤Ï¤¤¤Ã¤Ñ¤¤¤¤¤ë¡£"
¤ß¤¿¤¤¤Ê¤³¤È¤ò¤ª¤Ã¤·¤ã¤Ã¤Æ¤Þ¤·¤¿¡£¸¶Ê¸¥Þ¥Þ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£²¶¤ÎǾÆâ¥Õ¥£¥ë¥¿¡¼³Ý¤«¤Ã¤Æ¤Þ¤¹¡£
¥Ó¥Ç¥ª¤È¤Ã¤ÆÌµ¤«¤Ã¤¿¤Î¤Ç¡£14»þ²á¤®¤Ç¤¹¡£
ÍפϤ³¤Î¹ñ¤Ï¶ò̱¤Ð¤Ã¤«¡£´Å¤¤Ïä˾褻¤é¤ì¤ë¶ò̱¤Ð¤Ã¤«¡£¤À¤«¤éÀ¯¼£²È¤ÏÀè¤ò¸«Ä̤·¡¢´¶¾ð¤Ç¤Ï¤Ê¤¯ÃÎÀ¤ò¤â¤Ã¤ÆÀ¯¼£¤ËÅö¤¿¤é¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£
¤³¤¦Ê¹¤³¤¨¤Þ¤·¤¿¡£Á´¤¯¤½¤ÎÄ̤ê¤À¤È»×¤¤¤Þ¤¹¡£
¤½¤ÎÅö¿Í¤Ë¤Ï³°¹ñ¿Í»²À¯¸¢¤òÄ̤·¤¿¾ì¹ç¡¢¤É¤¦¤Ê¤ë¤Î¤«¤ò¹Í¤¨¤Æ¤Û¤·¤¤¤Î¤Ç¤¹¤¬¡£¤Í¡£
¤Þ¤¡²¶¤ÎÆáÇÆÃϸ¡¤ËÂФ¹¤ëºÇ½é¤Î¸«Î©¤Æ¤â³°¤ì¤¿¤Î¤Ç¡¢¤¨¤é¤½¤Ê¤³¤È¤Ï¸À¤¨¤Þ¤»¤ó¤±¤É¤Í¡£
¤Ç¡¢º£¡¢·ì´ã¤Ë¤Ê¤Ã¤ÆÈÈ¿Íõ¤·¤¬¹Ô¤ï¤ì¤Æ¤¤¤ë¤è¤¦¤ÊÊ·°Ïµ¤¤Ç¤¹¤¬¡£
¥Þ¥¹¥³¥ß¤¬¤¹¤Ã¤ÑÈ´¤¤¤¿¤é"ÆÃ¥À¥Í"¤Ç¤¢¤Ã¤Æ¡¢
°ìÈ̿ͤ¬youtube¤ËÅê¹Æ¤·¤¿¤é"ÈȺá¼Ô"¤Ê¤ó¤Ç¤¹¤Í¡£
¤ª¤«¤·¤ÊÏäǤ¹¤è¤Í¡£
¤µ¤é¤Ë¡¢¸ø³«¤»¤è¤ÈÀ¤ÏÀ¤òÀú¤Ã¤Æ¤¿¤Ï¤º¤Ê¤ó¤Ç¤¹¤è¤Í¡¢¥Þ¥¹¥³¥ß¡£
¤Ç¤â¡¢¼«Ê¬¤é¤Î¼ê¤ò·Ð¤Ê¤¤¤Ç°ìÈ̤ËήÄ̤·¤Æ¤·¤Þ¤Ã¤¿¤é°ãË¡¤Ê¤ó¤Ç¤¹¤Í¡£¤½¤¦¤Ç¤¹¤«¡£
¤¢¤ó¤¿¤éˡΧ¤Ê¤ó¤À¡©²¿ÍͤΤĤâ¤ê¡©¤Ã¤Æ¤Î¤¬´¶ÁۤǤ¹¡£
¤³¤ó¤Ê¤ó¤À¤«¤é¡¢¥Þ¥¹¡û¥ß¤Ã¤Æ¸À¤ï¤ì¤ë¤ó¤À¤ï¡£
¤Þ¤¡¤·¤«¤·¡¢À¯Éܤ¬Èó¸ø³«¡¢¤Ã¤Æ¸À¤Ã¤Æ¤¤¤ë¡¢³°¸ò¾å¤â½ÅÍפʻñÎÁ¤¬¤³¤¦¤â´Êñ¤Ëή¤ì½Ð¤ë¤Î¤Ï¤½¤ì¤Ï¤½¤ì¤ÇÌäÂê¤À¤È»×¤¤¤Þ¤¹¤¬¡£
¸ø³«¤ÈÈó¸ø³«¤Î´Ö¤ò¤È¤Ã¤Æ¡¢Î®½Ð¡¢¤È¤¤¤¦ÁªÂò»è¤ò¼è¤Ã¤¿¤Î¤«¤È¡¢Àü¤Ã¤¿¸«Êý¤â¤Ç¤¤Þ¤¹¤¬¡£
ÆÀ°Õ¤Î¶ÌÃî¿§¤Ç¡£
¤Ç¤â¤Ç¤¹¤è¡£¤½¤ì¤è¤ê½ÅÍפʤΤϡ¢À¯ÉܤÎÂбþ¤Ç¤·¤ç¤¦¡£
Ãæ¹ñÀ¯ÉܤϥӥǥªÎ®½Ð¸å¤â¡¢"ÆüËܤ¬°¤¤"¤ÎΩ¾ì¤òÊø¤µ¤º¡¢À¯Éܤ¬¸ø¼°¸«²ò¤òÏ¢Æüȯ¿®¤·¤Æ¤¤¤Þ¤¹¡£
¤·¤«¤·¡¢¤³¤Î¹ñ¤Ï¤É¤¦¤Ç¤·¤ç¤¦¡£
¸½ºß¸¡¾ÚÃæ¤Ç¤¹¢ª¤É¤¦¤ä¤é¥Ó¥Ç¥ª¤ÏËÜʪ¤é¤·¤¤¡¢Èȿͤòõ¤»
¤·¤«¥¢¥Ê¥¦¥ó¥¹¤µ¤ì¤Æ¤¤¤Ê¤¤¤è¡¼¤Êµ¤¤¬¤¹¤ë¤Î¤Ç¤¹¤¬¡£
¥Þ¥º¥´¥ß¥Õ¥£¥ë¥¿¡¼¤Ç¤·¤ç¤¦¤«¡©
ή½Ð¤·¤¿¤Î¤Ï¤Þ¤¡Îɤ¤¤È¤·¤Æ¡¢
"ή½Ð¤Ï°ä´¸¤Ç¤¹¤¬¡¢¤½¡¼¤ì¤ß¤í¡¢°¤¤¤Î¤Ï¤ª¤á¡¼¤é¤À"
¤¯¤é¤¤¤Îȯɽ¤¬¤¢¤Ã¤Æ¤â¤è¤¤¤È»×¤¤¤Þ¤¹¡£
¤È¤¤¤¦¤«¡¢¤½¤ì¤¯¤é¤¤¼çÄ¥¤·¤Ê¤¤¤ÈÀ¤³¦¤ÏÃæ¹ñ¤Î¸À¤¤Ê¬¤·¤«¤¤«¤Ê¤¤¤³¤È¤Ë¤Ê¤ë¤ó¤Ç¤¹¡£
¹ñ²ñ¤ÇÁ°¸¶Âç¿Ã¤¬
"ÎÎÅÚÌäÂê¤Ï¸ºß¤·¤Ê¤¤¤Î¤À¤«¤é·öÅÁ¤·¤Ê¤¯¤Æ¤è¤¤¡£¼Â¸ú»ÙÇÛ¤ò³¤±¤ì¤Ð¤è¤¤"
¤È¤Î¤¿¤Þ¤Ã¤Æ¤ª¤ê¤Þ¤¹¤¬¡£
Á´¤¯¸«²ò¤ò½Ò¤Ù¤Ê¤¤¤Î¤Ï¤É¤¦¤Ê¤ó¤Ç¤·¤ç¤¦¡£
¤È»×¤¦¤Î¤Ç¤¹¡£
¤·¤«¤·¡¢º£Æü¤ÎÀÐÇˤµ¤ó¡¢¥¥ì¥¥ì¤Ã¤¹¤Í¤§¡£
Àí³Õ¤Î¸å¤Î¡¢ºâÀ¯¤Î¤ªÏäÇ
"̱¼ç¼çµÁ¤ÏÆâÉôÊø²õ¤¹¤ë¡£¤¢¤ì¤â¥¿¥À¡¢¤³¤ì¤â¥¿¥À¡¢ÌµÂ̤ò¾Ê¤±¤Ð¶â¤ò¤ï¤¤¤Æ¤¯¤ë¡£¤³¤ì¤Çɼ¤ò½¸¤á¤ë¿Í¤Ï¤¤¤ë¤·¡¢¤½¤ó¤ÊͶÏǤËή¤µ¤ì¤ë¿Í¤â¤¤¤ë¡£¤·¤«¤·¤½¤ì¤Ï±³¤À¤È¤ä¤¬¤Æ¤ï¤«¤ë¡£Í¶ÏǤËή¤µ¤ì¤ë¿Í¤Ï¤¤¤Ã¤Ñ¤¤¤¤¤ë¡£"
¤ß¤¿¤¤¤Ê¤³¤È¤ò¤ª¤Ã¤·¤ã¤Ã¤Æ¤Þ¤·¤¿¡£¸¶Ê¸¥Þ¥Þ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£²¶¤ÎǾÆâ¥Õ¥£¥ë¥¿¡¼³Ý¤«¤Ã¤Æ¤Þ¤¹¡£
¥Ó¥Ç¥ª¤È¤Ã¤ÆÌµ¤«¤Ã¤¿¤Î¤Ç¡£14»þ²á¤®¤Ç¤¹¡£
ÍפϤ³¤Î¹ñ¤Ï¶ò̱¤Ð¤Ã¤«¡£´Å¤¤Ïä˾褻¤é¤ì¤ë¶ò̱¤Ð¤Ã¤«¡£¤À¤«¤éÀ¯¼£²È¤ÏÀè¤ò¸«Ä̤·¡¢´¶¾ð¤Ç¤Ï¤Ê¤¯ÃÎÀ¤ò¤â¤Ã¤ÆÀ¯¼£¤ËÅö¤¿¤é¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£
¤³¤¦Ê¹¤³¤¨¤Þ¤·¤¿¡£Á´¤¯¤½¤ÎÄ̤ê¤À¤È»×¤¤¤Þ¤¹¡£
¤½¤ÎÅö¿Í¤Ë¤Ï³°¹ñ¿Í»²À¯¸¢¤òÄ̤·¤¿¾ì¹ç¡¢¤É¤¦¤Ê¤ë¤Î¤«¤ò¹Í¤¨¤Æ¤Û¤·¤¤¤Î¤Ç¤¹¤¬¡£¤Í¡£
¤Þ¤¡²¶¤ÎÆáÇÆÃϸ¡¤ËÂФ¹¤ëºÇ½é¤Î¸«Î©¤Æ¤â³°¤ì¤¿¤Î¤Ç¡¢¤¨¤é¤½¤Ê¤³¤È¤Ï¸À¤¨¤Þ¤»¤ó¤±¤É¤Í¡£